Growth Metrics

Exact Sciences (EXAS) Cash from Financing Activities (2016 - 2025)

Exact Sciences (EXAS) has disclosed Cash from Financing Activities for 16 consecutive years, with -$75.9 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 822.67% to -$75.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$338.1 million through Dec 2025, down 245.81% year-over-year, with the annual reading at -$338.1 million for FY2025, 245.81% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$75.9 million at Exact Sciences, down from -$1.5 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $224.6 million in Q2 2024, with the low at -$256.2 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is $6.9 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Cash from Financing Activities surged 4784.68% in 2023, then plummeted 8433.34% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$12.2 million in 2021, then surged by 182.84% to $10.1 million in 2022, then decreased by 0.65% to $10.0 million in 2023, then rose by 4.6% to $10.5 million in 2024, then crashed by 822.67% to -$75.9 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$75.9 million, -$1.5 million, and -$4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.